氯沙坦对2型糖尿病肾病患者尿8-羟基脱氧鸟嘌呤的影响
摘要
目的通过检测2型糖尿病肾病患者尿8-OHdG的水平,探讨氯沙坦对DN患者机体氧化损伤的影响。方法检测30例糖尿病肾病患者氯沙坦治疗前后24h尿蛋白、尿肌酐、尿8-羟基脱氧鸟嘌呤(8-OHdG)水平。8-OHdG检测采用毛细管电泳和液相色谱法。结果2型糖尿病肾病患者尿8-OHdG水平明显升高(32.84±19.68)ng/mgCr,经氯沙坦治疗8周后,8-OHdG水平明显降低(23.34±14.48)ng/mgCr(P〈0.01)。结论2型糖尿病肾病患者机体氧化损伤明显;氯沙坦可降低患者尿中8-OHdG水平,抑制氧化应激损伤。
出处
《中国医师杂志》
CAS
2007年第1期122-123,共2页
Journal of Chinese Physician
基金
上海市科委计划资助项目(03JC14084)
参考文献8
-
1Leinonen J, Lehtimaki T, Toyokuni S, et al. New biomarker evldence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett, 1997,417 ( 1 ) : 150-152.
-
2Vinik AI, Mehrabyan A. Diabetic neuropathies. Med Clin North Am, 2004,88 ( 4 ) : 947 -999.
-
3陈秋,胡怀东,严钟德,夏永鹏.内皮损伤和氧化应激与糖尿病肾小管病变的关系[J].中国糖尿病杂志,2003,11(2):136-137. 被引量:8
-
4Wu LL, Chiou CC, Chang PY, et al. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta,2004,339(1-2) :1-9.
-
5Piconi L, Quagliaro L, Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med,2003,41 (9) :1144-1149.
-
6Koya D, Hayashi K, Kitada M, et al. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol,2003,14 ( 8 Suppl 3 ) :250-253.
-
7Donmez G, Derici U, Erbas D, et al. The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension. Jpn J Physiol, 2002,52(5) :435-440.
-
8Onozato ML, Tojo A, Goto A, et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int,2002,61 ( 1 ) :186-194.
二级参考文献5
-
1Sharpe PC, Liu WH, Yue KKM, et al. Glucose-induced oxidative stress in vascular contractile cells. Diabetes, 1998,47:801-809.
-
2Steouwer CDA, Fischer HRA, Kuijk AWR, et al. Endothelial dysfunction precedes development of microalbuminuria in IDDM.Diabetes, 1995,44 : 561-564.
-
3Yaqoob M, McClelland P, Patrick AW, et al. Evidence of oxidant injury and tubular damage in early diabetic nephropathy.QJM, 1994,87:601-607.
-
4Cominacini L, Garbin U, Pasini AF, et al. Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients. Diabetes, 1998,47 : 130-133.
-
5Ting HH, Timimi FK, Boles KS, et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulindependent diabetes mellitus ,J Clin Invest, 1998,97 : 22-28.
共引文献7
-
1朱志明,张涛,吴国富.2型糖尿病早期肾小管功能损害的探讨[J].现代实用医学,2009,21(4). 被引量:3
-
2朱微,张苗,顾勇.双倍剂量氯沙坦对糖尿病肾病患者机体DNA氧化损伤的影响[J].临床内科杂志,2009,26(1):38-40. 被引量:3
-
3陈幼发.糖尿病大鼠肾小管-间质Prohibitin的表达[J].四川医学,2009,30(5):634-636. 被引量:2
-
4殷松楼,周冬梅,奚珏,殷寒秋.2型糖尿病患者氧化应激指标的变化[J].徐州医学院学报,2010,30(1):63-64. 被引量:24
-
5古艺儿,曹伍兰,陈宏霞.妊娠期糖尿病患者氧化应激失衡与胎盘血流异常的关系[J].广东医学,2012,33(21):3259-3261. 被引量:7
-
6吴宏,卢莉萍,丁伟,陈倩倩.8-iso-PGF2α在妊娠期糖尿病孕妇羊水中的检测及临床意义[J].中国伤残医学,2014,22(7):180-181.
-
7吴宏,卢莉萍,丁伟,魏红艳,陈倩倩.8-iso-PGF2α与HbA1c在妊娠期糖尿病中的相关探讨[J].哈尔滨医药,2015,35(1):32-33.
-
1王改峰.恩替卡韦治疗乙肝相关性肾炎疗效观察[J].中国误诊学杂志,2012,12(13):3199-3200. 被引量:3
-
2高波,王彦荣.恩替卡韦治疗失代偿期乙型肝炎肝硬化126例分析[J].中国误诊学杂志,2011,11(25):6199-6200. 被引量:4
-
3陈志忠,林远杰,黄建华.来氟米特联合恩替卡韦治疗乙型肝炎病毒相关性肾炎11例分析[J].中国误诊学杂志,2012,12(7):1703-1703. 被引量:1
-
4郭强,郝建忠,王爱丽,刘宏斌,宋晨,于卫平.急性颅脑损伤脑脊液中谷氨酸含量变化的临床意义[J].中华创伤杂志,2004,20(1):14-14.
-
5麦水强,庞国象,李有国.霉酚酸酯治疗紫癜性肾炎的临床观察[J].中国误诊学杂志,2009,9(22):5348-5349. 被引量:6
-
6杨庆兵,于明涛,潘红霞,于松杨.氯诺昔康与芬太尼术后静脉自控镇痛的疗效观察[J].中国误诊学杂志,2006,6(13):2514-2515. 被引量:1
-
7林金兵,胡旭东,吴亚彬,何仁亮.氯诺昔康用于妇科腹腔镜手术后镇痛疗效观察[J].中国误诊学杂志,2008,8(24):5860-5860. 被引量:1
-
8杨庆兵,李云峰.氯诺昔康与芬太尼在全麻恢复期的临床应用[J].中国误诊学杂志,2007,7(9):1959-1960. 被引量:5
-
9肖振忠,孙宏君.恩替卡韦治疗乙肝相关性肾炎疗效分析[J].中国误诊学杂志,2009,9(31):7628-7628. 被引量:5
-
10王颖.高乌甲素联合舒芬太尼在术后静脉自控镇痛中的应用[J].现代医药卫生,2013,29(20):3128-3129. 被引量:1